Each year, millions of people are diagnosed with cancer around the world. Although there has been a considerable improvement in therapeutic options against cancer, it still remains one of the major causes of death worldwide. BeiGene is dedicated to discovering, innovating and developing better treatment against cancer to create a lasting impact on the patients with a mission to become a global leader in oncology research.


Cancer takes. Takes away time. Takes away loved ones. At Boehringer Ingelheim Oncology, we are giving patients new hope, by taking cancer on. We are dedicated to collaborating with the oncology community on a shared journey to deliver leading science. Our goal is treatment breakthroughs that can transform the lives of patients and help win the fight against cancer.


ITM is developing a proprietary portfolio and precision oncology pipeline of targeted treatments in various stages of clinical development, which address a broad range of cancers. By leveraging its nearly two decades of pioneering radiopharma expertise, central industry position and established global network, ITM strives to provide patients with more effective targeted treatment to improve clinical outcomes and quality of life.